Loading...
Please wait while we get things ready for you
Please wait while we get things ready for you
The FDA has approved four updated COVID-19 vaccines for the 2026–2027 season, all targeting the JN.1-lineage XFG variant. The vaccines, from Moderna, Novavax-Sanofi, and Pfizer-BioNTech, are approved for adults 65 and older and younger high-risk individuals. This is the first major seasonal update since the variant became globally dominant.
The approvals come as a new UC Irvine study reveals how high-fructose corn syrup might secretly promote weight gain....
Ask AI about this